2.22

1.37% 0.03

After Hours: 2.30 0.08 +3.60%

Galectin Therapeutics Inc (GALT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Galectin Therapeutics Inc stock is traded at $2.22, with a volume of 517.14K. It is up +1.37% in the last 24 hours and down -28.39% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Previous Close:

$2.19

Open:

$2.24

24h Volume:

517.14K

Relative Volume:

1.46

Market Cap:

$146.14M

Revenue:

Net Income/Loss:

$-30.84M

P/E Ratio:

-4.5783

EPS:

-0.4849

Net Cash Flow:

$-23.88M

1W Performance:

-17.16%

1M Performance:

-28.39%

6M Performance:

-53.16%

1Y Performance:

+74.80%

1-Day Range:

$2.20

$2.39

1-Week Range:

$2.18

$2.77

52-Week Range:

$1.21

$7.13

Galectin Therapeutics Inc Stock (GALT) Company Profile

Name

Galectin Therapeutics Inc

Sector

Healthcare (1111)

Industry

Biotechnology (624)

Phone

678-620-3186

Address

4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA

Employee

Twitter

@galectingalt

Next Earnings Date

2026-03-30

Latest SEC Filings

GALT's Discussions on Twitter

Compare GALT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GALT Galectin Therapeutics Inc	2.22	144.16M	0	-30.84M	-23.88M	-0.4849
VRTX Vertex Pharmaceuticals Inc	443.92	109.85B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	775.53	80.38B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	785.07	47.60B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	327.25	42.63B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	312.19	33.72B	5.36B	287.73M	924.18M	2.5229

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-17-25	Resumed	H.C. Wainwright	Buy
Aug-13-20	Reiterated	H.C. Wainwright	Buy
Feb-13-19	Initiated	B. Riley FBR	Buy
Dec-07-17	Reiterated	H.C. Wainwright	Buy
Nov-28-17	Reiterated	H.C. Wainwright	Buy
Oct-19-17	Initiated	ROTH Capital	Buy
Mar-30-17	Upgrade	H.C. Wainwright	Neutral → Buy
Oct-03-16	Downgrade	FBR & Co.	Outperform → Mkt Perform
Sep-29-16	Downgrade	H.C. Wainwright	Buy → Neutral
Sep-28-16	Downgrade	ROTH Capital	Buy → Sell
Mar-28-16	Resumed	H.C. Wainwright	Buy
Sep-21-15	Initiated	H.C. Wainwright	Buy
Aug-01-14	Downgrade	Aegis Capital	Buy → Hold
Jul-30-14	Reiterated	MLV & Co	Buy
Jul-29-14	Reiterated	MLV & Co	Buy
Apr-02-14	Reiterated	MLV & Co	Buy
Feb-10-14	Reiterated	Aegis Capital	Buy
Jan-09-14	Reiterated	Aegis Capital	Buy
Dec-03-13	Initiated	MLV & Co	Buy
Aug-19-13	Reiterated	Aegis Capital	Buy

View All

Galectin Therapeutics Inc Stock (GALT) Latest News

Apr 07, 2026

Earnings Risk: Is Galectin Therapeutics Inc stock a buy or sell2026 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Trend Recap: What is the long term forecast for Galectin Therapeutics Inc stock2026 Summary & Consistent Return Investment Signals - baoquankhu1.vn

Apr 06, 2026

Apr 05, 2026

Galectin Therapeutics (GALT) Eps Diluted (TTM) - Zacks Investment Research

Apr 05, 2026

Apr 04, 2026

Galectin Therapeutics (GALT) upgraded to buy: What does it mean for the stock? - MSN

Apr 04, 2026

Apr 03, 2026

Galectin Therapeutics Inc. (PHPN.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore

Apr 03, 2026

Galectin Therapeutics (GALT) Receives Buy Rating: How Will This Impact the Shares? - Bitget

Apr 03, 2026

Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2026

HC Wainwright Boosts FY2026 Earnings Estimate for Galectin Therapeutics - National Today

Apr 03, 2026

FY2026 Earnings Estimate for GALT Issued By HC Wainwright - marketbeat.com

Apr 03, 2026

Apr 02, 2026

Aug PostEarnings: Can Galectin Therapeutics Inc reach all time highs this year2026 Trading Recap & Verified Swing Trading Watchlist - baoquankhu1.vn

Apr 02, 2026

What is HC Wainwright's Estimate for GALT Q1 Earnings? - MarketBeat

Apr 02, 2026

GALT Stock Price, Quote & Chart | GALECTIN THERAPEUTICS INC (NASDAQ:GALT) - ChartMill

Apr 02, 2026

Apr 01, 2026

Galectin Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2026

Mar 31, 2026

Galectin Therapeutics (NASDAQ: GALT) launches $32.5M ATM; 3% agent fee - Stock Titan

Mar 31, 2026

Galectin Therapeutics Reports 2025 Financial Results, Advances Belapectin Program for MASH Cirrhosis, and Extends Cash Runway Through 2027 - Minichart

Mar 31, 2026

Galectin Therapeutics Reports 2025 Financial Results - nationaltoday.com

Mar 31, 2026